Original news and analysis on international IP policy
Protection of pharmaceutical patents may not be the biggest reason the Bush administration is struggling to line up congressional votes for a free trade agreement with five Central American countries and the Dominican Republic, but it remains critical to its…
Recent efforts to rally Congress to approve a Free Trade Agreement (FTA) reached earlier this year with Central American countries has reignited debate about USTR’s approach to intellectual property and the implications for access to essential medicines. The Agreement with…
In the wake of a series of U.S. free trade agreements (FTAs) which include ‘TRIPS-plus’ commitments on intellectual property, civil society groups are again urging the United States to better incorporate public interest views in the formulation of its trade…